A nonprofit lab in Bothell is doubling down on a cancer test that tries drugs out on a patient's own tumor cells before a ...
The Seattle-based nonprofit plans to more than double testing volume for the functional cancer test, called the PARIS Test®, ...
YD Bio Limited (“YD Bio” or the “Company”) (Nasdaq: YDES), a biotechnology company advancing DNA methylation-based cancer detection technology and ophthalmologic innovations, today announced that the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results